Smoking Cessation Intervention in Public Housing
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01035151|
Recruitment Status : Unknown
Verified December 2009 by Medical University of South Carolina.
Recruitment status was: Enrolling by invitation
First Posted : December 18, 2009
Last Update Posted : December 18, 2009
The major aim of this study is to test the effectiveness of a bundled, multi-level intervention (Sister to Sister) on smoking cessation outcomes in female smokers residing in public housing neighborhoods.
Hypothesis 1.1: As compared to the control group, women receiving the Sister to Sister Intervention will have higher 7-day point prevalence quit rates at 6- and 12-months as validated by salivary cotinine.
Hypothesis 1.2: As compared to the control group, women receiving the Sister to Sister Intervention will have higher 6- and 12-month prolonged smoking abstinence as validated by salivary cotinine.
|Condition or disease||Intervention/treatment||Phase|
|Cigarette Smoking||Behavioral: Sister to Sister Behavioral: Control||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||420 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Double (Participant, Outcomes Assessor)|
|Official Title:||Social Ecological Based Smoking Cessation Intervention in Public Housing Neighborhoods|
|Study Start Date :||July 2009|
|Estimated Primary Completion Date :||March 2013|
|Estimated Study Completion Date :||December 2013|
|Experimental: Bundled Intervention||
Behavioral: Sister to Sister
Neighborhood level interventions, peer group (counseling, NRT), and individual level (Coach/CHW)
|Experimental: Delayed Control||
Written Cessation Materials
- smoking abstinence [ Time Frame: 6 and 12 month ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01035151
|United States, Georgia|
|Medical College of Georgia|
|Augusta, Georgia, United States, 30901|
|United States, South Carolina|
|Medical University of South Carolina|
|Charleston, South Carolina, United States, 29425|
|Principal Investigator:||Jeannette Andrews, PhD||Medical University of South Carolina|